These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30530727)

  • 1. Direct reprogramming of fibroblasts into antigen-presenting dendritic cells.
    Rosa FF; Pires CF; Kurochkin I; Ferreira AG; Gomes AM; Palma LG; Shaiv K; Solanas L; Azenha C; Papatsenko D; Schulz O; Reis e Sousa C; Pereira CF
    Sci Immunol; 2018 Dec; 3(30):. PubMed ID: 30530727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct Reprogramming of Mouse Embryonic Fibroblasts to Conventional Type 1 Dendritic Cells by Enforced Expression of Transcription Factors.
    Rosa FF; Pires CF; Zimmermannova O; Pereira CF
    Bio Protoc; 2020 May; 10(10):e3619. PubMed ID: 33659292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-cell transcriptional profiling informs efficient reprogramming of human somatic cells to cross-presenting dendritic cells.
    Rosa FF; Pires CF; Kurochkin I; Halitzki E; Zahan T; Arh N; Zimmermannová O; Ferreira AG; Li H; Karlsson S; Scheding S; Pereira CF
    Sci Immunol; 2022 Mar; 7(69):eabg5539. PubMed ID: 35245086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
    Bodey B; Bodey B; Kaiser HE
    In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The DNA damage response induces antigen presenting cell-like functions in fibroblasts.
    Tang ML; Khan MK; Croxford JL; Tan KW; Angeli V; Gasser S
    Eur J Immunol; 2014 Apr; 44(4):1108-18. PubMed ID: 24375454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cells in distinct oral mucosal tissues engage different mechanisms to prime CD8+ T cells.
    Nudel I; Elnekave M; Furmanov K; Arizon M; Clausen BE; Wilensky A; Hovav AH
    J Immunol; 2011 Jan; 186(2):891-900. PubMed ID: 21160044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding and Modulating Immunity With Cell Reprogramming.
    Pires CF; Rosa FF; Kurochkin I; Pereira CF
    Front Immunol; 2019; 10():2809. PubMed ID: 31921109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD36 or alphavbeta3 and alphavbeta5 integrins are not essential for MHC class I cross-presentation of cell-associated antigen by CD8 alpha+ murine dendritic cells.
    Schulz O; Pennington DJ; Hodivala-Dilke K; Febbraio M; Reis e Sousa C
    J Immunol; 2002 Jun; 168(12):6057-65. PubMed ID: 12055214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokines in the generation and maturation of dendritic cells: recent advances.
    Zou GM; Tam YK
    Eur Cytokine Netw; 2002; 13(2):186-99. PubMed ID: 12101074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential delivery of maturation stimuli increases human dendritic cell IL-12 production and enhances tumor antigen-specific immunogenicity.
    Kalady MF; Onaitis MW; Emani S; Abdel-Wahab Z; Tyler DS; Pruitt SK
    J Surg Res; 2004 Jan; 116(1):24-31. PubMed ID: 14732346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitization of cisplatin resistant bladder tumor by combination of cisplatin treatment and co-culture of dendritic cells with apoptotic bladder cancer cells.
    Zhang Q; Chen Z
    Cell Mol Biol (Noisy-le-grand); 2018 Jul; 64(10):102-107. PubMed ID: 30084800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EBV-induced gene 3 transcription is induced by TLR signaling in primary dendritic cells via NF-kappa B activation.
    Wirtz S; Becker C; Fantini MC; Nieuwenhuis EE; Tubbe I; Galle PR; Schild HJ; Birkenbach M; Blumberg RS; Neurath MF
    J Immunol; 2005 Mar; 174(5):2814-24. PubMed ID: 15728491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological Reprogramming of Somatic Cells for Regenerative Medicine.
    Xie M; Tang S; Li K; Ding S
    Acc Chem Res; 2017 May; 50(5):1202-1211. PubMed ID: 28453285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. APC stimulated by CpG oligodeoxynucleotide enhance activation of MHC class I-restricted T cells.
    Warren TL; Bhatia SK; Acosta AM; Dahle CE; Ratliff TL; Krieg AM; Weiner GJ
    J Immunol; 2000 Dec; 165(11):6244-51. PubMed ID: 11086059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sialic acid removal from dendritic cells improves antigen cross-presentation and boosts anti-tumor immune responses.
    Silva M; Silva Z; Marques G; Ferro T; Gonçalves M; Monteiro M; van Vliet SJ; Mohr E; Lino AC; Fernandes AR; Lima FA; van Kooyk Y; Matos T; Tadokoro CE; Videira PA
    Oncotarget; 2016 Jul; 7(27):41053-41066. PubMed ID: 27203391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Batf3 selectively determines acquisition of CD8
    Chandra J; Kuo PT; Hahn AM; Belz GT; Frazer IH
    Immunol Cell Biol; 2017 Feb; 95(2):215-223. PubMed ID: 27897162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High transfection efficiency, gene expression, and viability of monocyte-derived human dendritic cells after nonviral gene transfer.
    Landi A; Babiuk LA; van Drunen Littel-van den Hurk S
    J Leukoc Biol; 2007 Oct; 82(4):849-60. PubMed ID: 17626798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation.
    Singh SK; Stephani J; Schaefer M; Kalay H; García-Vallejo JJ; den Haan J; Saeland E; Sparwasser T; van Kooyk Y
    Mol Immunol; 2009 Dec; 47(2-3):164-74. PubMed ID: 19818504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trogocytosis of peptide-MHC class II complexes from dendritic cells confers antigen-presenting ability on basophils.
    Miyake K; Shiozawa N; Nagao T; Yoshikawa S; Yamanishi Y; Karasuyama H
    Proc Natl Acad Sci U S A; 2017 Jan; 114(5):1111-1116. PubMed ID: 28096423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of mouse pluripotent stem cell-derived proliferating myeloid cells as an unlimited source of functional antigen-presenting cells.
    Zhang R; Liu TY; Senju S; Haruta M; Hirosawa N; Suzuki M; Tatsumi M; Ueda N; Maki H; Nakatsuka R; Matsuoka Y; Sasaki Y; Tsuzuki S; Nakanishi H; Araki R; Abe M; Akatsuka Y; Sakamoto Y; Sonoda Y; Nishimura Y; Kuzushima K; Uemura Y
    Cancer Immunol Res; 2015 Jun; 3(6):668-77. PubMed ID: 25672396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.